The new Congressional Budget Office report looked at growth in the 340B program between 2010 and 2021.

CBO Report Requested by GOP Congressional Committee Chairs Links 340B Growth to Drug Spending Trends, ACA-Related Changes and Contract Pharmacy Use Expansion

340B covered entities in the prime vendor program (PVP) spent nearly $44 billion on 340B drugs in 2021—up from $6.6 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live